Caterina Mele

Bergamo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Sustained terminal complement inhibition on the endothelium with ravulizumab in patients with atypical Haemolytic Uremic Syndrome.

Sustained terminal complement inhibition on the endothelium with ravulizumab in patients with atypical Haemolytic Uremic Syndrome.

Journal: Nephron

Published: March 05, 2026

Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background.

Pegcetacoplan prophylaxis for recurrent C3 glomerulopathy with multifactorial genetic background.

Journal: Kidney international

Published: November 25, 2025

Complement-Mediated Postpartum Atypical Hemolytic Uremic Syndrome With Collapsing Focal Segmental Glomerulosclerosis Associated With a Novel CFHR5 Copy Number Variant.

Complement-Mediated Postpartum Atypical Hemolytic Uremic Syndrome With Collapsing Focal Segmental Glomerulosclerosis Associated With a Novel CFHR5 Copy Number Variant.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: September 15, 2025

Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy.

Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy.

Journal: Kidney international

Published: February 11, 2025

Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy.

Exuberant Endothelial C5b-9 Formation in Recurrent and De Novo Posttransplant Thrombotic Microangiopathy.

Journal: Kidney international reports

Published: June 11, 2024

"Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.

"Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.

Journal: Kidney international reports

Published: October 31, 2023

Lysinuric Protein Intolerance: Not Only a Disorder for Pediatric Nephrologists - Case Report.

Lysinuric Protein Intolerance: Not Only a Disorder for Pediatric Nephrologists - Case Report.

Journal: Nephron

Published: May 23, 2023

A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals.

A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals.

Journal: iScience

Published: May 16, 2023

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome.

An ex vivo test to investigate genetic factors conferring susceptibility to atypical haemolytic uremic syndrome.

Journal: Frontiers in immunology

Published: November 30, 2022

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.

Journal: Frontiers in immunology

Published: August 04, 2022

Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.

Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022.

Journal: Respiratory medicine and research

Published: June 13, 2022

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19.

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19.

Journal: Frontiers in pharmacology

Published: December 23, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026